Immunohistochemistry examination showed that CRC earl markers, including Ki67, COX2, and EMR1, were highly expressed in the colons in the model group, but these indicators showed lower expression in the APE and AFE intervention groups than in the model group. The gene discussed is ADGRE1; the disease is colorectal carcinoma.